drugset / Trial / NCT04760717

Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

NCT04760717

Phase 2 Active not recruiting 160 enrolled Yale University American Heart Association · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering blood pressure in stroke survivors.

Timeline

Start
2021-03-19
Primary completion
2026-02-02
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Spironolactone Small molecule